发明名称 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES
摘要 The invention relates to substituted-pyrimidone derivatives represented by formula (I) or a salt thereof: wherein: X represents two hydrogen atoms, a sulfur atom, an oxygen atom or a C1-2 alkyl group and a hydrogen atom; Y represents a bond, a carbonyl group, a methylene group optionally substituted; R1 represents a 2, 3 or 4- pyridine ring or a 2, 4 or 5-pyrimidine ring, the rings being optionally substituted; R2 represents a phenyl group or a naphthalene ring; the phenyl group and the naphthalene ring being optionally substituted; R3 represents a hydrogen atom or a C1-6 alkyl group; R4 represents a phenyl group, a pyridinyl group or a naphthalene ring, the groups and the ring being optionally substituted; R5 represents a hydrogen atom, a C1-6 alkyl group or a halogen atom; n represents 0 to 3; and p+ q=0-3. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3beta, such as Alzheimer disease.
申请公布号 KR20050111782(A) 申请公布日期 2005.11.28
申请号 KR20057017572 申请日期 2005.09.20
申请人 SANOFI-AVENTIS;MITSUBISHI PHARMA CORPORATION 发明人 LOCHEAD ALISTAIR;SAADY MOURAD;SLOWINSKI FRANCK;YAICHE PHILIPPE
分类号 A61K;A61K31/519;A61P25/00;C07D;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K
代理机构 代理人
主权项
地址